Efficacy of a Single Injection of Stromal Vascular Fraction in Dogs with Elbow Osteoarthritis: A Clinical Prospective Study

This study aimed to assess the efficacy of a single intra-articular injection of autologous stromal vascular fraction (SVF) in dogs with chronic lameness due to advanced elbow osteoarthritis (OA) that were unresponsive to conventional drug therapy. In this clinical, prospective, non-blinded, single-...

Full description

Saved in:
Bibliographic Details
Main Authors: Yvonne Bruns, Maike Schroers, Stephanie Steigmeier-Raith, Anja-Christina Waselau, Sven Reese, Andrea Meyer-Lindenberg
Format: Article
Language:English
Published: MDPI AG 2024-09-01
Series:Animals
Subjects:
Online Access:https://www.mdpi.com/2076-2615/14/19/2803
Tags: Add Tag
No Tags, Be the first to tag this record!
_version_ 1850283636425752576
author Yvonne Bruns
Maike Schroers
Stephanie Steigmeier-Raith
Anja-Christina Waselau
Sven Reese
Andrea Meyer-Lindenberg
author_facet Yvonne Bruns
Maike Schroers
Stephanie Steigmeier-Raith
Anja-Christina Waselau
Sven Reese
Andrea Meyer-Lindenberg
author_sort Yvonne Bruns
collection DOAJ
description This study aimed to assess the efficacy of a single intra-articular injection of autologous stromal vascular fraction (SVF) in dogs with chronic lameness due to advanced elbow osteoarthritis (OA) that were unresponsive to conventional drug therapy. In this clinical, prospective, non-blinded, single-center study, twenty-three dogs received autologous SVF derived from falciform adipose tissue. Primary outcome measures over the six-month study period included clinical-orthopedic and radiographic examinations, objective gait analysis and validated owner questionnaires. In 19 of 23 joints, no progression of OA was visible radiographically. Peak vertical force improved significantly at three months and vertical impulse at six months after the injection compared to baseline. Over 33% of dogs demonstrated treatment-related improvements in lameness based on objective gait analysis. Owner questionnaires indicated significant improvement in clinical signs throughout the study period and 26% of dogs showed treatment-related improvements in pain scores according to the Canine Brief Pain Inventory. No side effects were reported. These findings suggest that autologous regenerative cell therapy may provide a promising treatment option for dogs with advanced OA that do not respond to conventional drug therapy. However, the treatment did not improve the clinical symptoms in all dogs, so it cannot be recommended for all patients.
format Article
id doaj-art-4c8174afb2f848cfa583eff925e03de9
institution OA Journals
issn 2076-2615
language English
publishDate 2024-09-01
publisher MDPI AG
record_format Article
series Animals
spelling doaj-art-4c8174afb2f848cfa583eff925e03de92025-08-20T01:47:44ZengMDPI AGAnimals2076-26152024-09-011419280310.3390/ani14192803Efficacy of a Single Injection of Stromal Vascular Fraction in Dogs with Elbow Osteoarthritis: A Clinical Prospective StudyYvonne Bruns0Maike Schroers1Stephanie Steigmeier-Raith2Anja-Christina Waselau3Sven Reese4Andrea Meyer-Lindenberg5Clinic of Small Animal Surgery and Reproduction, Ludwig-Maximilians-Universität München, 80539 Munich, GermanyClinic of Small Animal Surgery and Reproduction, Ludwig-Maximilians-Universität München, 80539 Munich, GermanyClinic of Small Animal Surgery and Reproduction, Ludwig-Maximilians-Universität München, 80539 Munich, GermanyClinic of Small Animal Surgery and Reproduction, Ludwig-Maximilians-Universität München, 80539 Munich, GermanyDepartment of Veterinary Sciences, Ludwig-Maximilians-Universität München, 80539 Munich, GermanyClinic of Small Animal Surgery and Reproduction, Ludwig-Maximilians-Universität München, 80539 Munich, GermanyThis study aimed to assess the efficacy of a single intra-articular injection of autologous stromal vascular fraction (SVF) in dogs with chronic lameness due to advanced elbow osteoarthritis (OA) that were unresponsive to conventional drug therapy. In this clinical, prospective, non-blinded, single-center study, twenty-three dogs received autologous SVF derived from falciform adipose tissue. Primary outcome measures over the six-month study period included clinical-orthopedic and radiographic examinations, objective gait analysis and validated owner questionnaires. In 19 of 23 joints, no progression of OA was visible radiographically. Peak vertical force improved significantly at three months and vertical impulse at six months after the injection compared to baseline. Over 33% of dogs demonstrated treatment-related improvements in lameness based on objective gait analysis. Owner questionnaires indicated significant improvement in clinical signs throughout the study period and 26% of dogs showed treatment-related improvements in pain scores according to the Canine Brief Pain Inventory. No side effects were reported. These findings suggest that autologous regenerative cell therapy may provide a promising treatment option for dogs with advanced OA that do not respond to conventional drug therapy. However, the treatment did not improve the clinical symptoms in all dogs, so it cannot be recommended for all patients.https://www.mdpi.com/2076-2615/14/19/2803osteoarthritiscubarthrosisregenerative cellsstromal vascular fractiondog
spellingShingle Yvonne Bruns
Maike Schroers
Stephanie Steigmeier-Raith
Anja-Christina Waselau
Sven Reese
Andrea Meyer-Lindenberg
Efficacy of a Single Injection of Stromal Vascular Fraction in Dogs with Elbow Osteoarthritis: A Clinical Prospective Study
Animals
osteoarthritis
cubarthrosis
regenerative cells
stromal vascular fraction
dog
title Efficacy of a Single Injection of Stromal Vascular Fraction in Dogs with Elbow Osteoarthritis: A Clinical Prospective Study
title_full Efficacy of a Single Injection of Stromal Vascular Fraction in Dogs with Elbow Osteoarthritis: A Clinical Prospective Study
title_fullStr Efficacy of a Single Injection of Stromal Vascular Fraction in Dogs with Elbow Osteoarthritis: A Clinical Prospective Study
title_full_unstemmed Efficacy of a Single Injection of Stromal Vascular Fraction in Dogs with Elbow Osteoarthritis: A Clinical Prospective Study
title_short Efficacy of a Single Injection of Stromal Vascular Fraction in Dogs with Elbow Osteoarthritis: A Clinical Prospective Study
title_sort efficacy of a single injection of stromal vascular fraction in dogs with elbow osteoarthritis a clinical prospective study
topic osteoarthritis
cubarthrosis
regenerative cells
stromal vascular fraction
dog
url https://www.mdpi.com/2076-2615/14/19/2803
work_keys_str_mv AT yvonnebruns efficacyofasingleinjectionofstromalvascularfractionindogswithelbowosteoarthritisaclinicalprospectivestudy
AT maikeschroers efficacyofasingleinjectionofstromalvascularfractionindogswithelbowosteoarthritisaclinicalprospectivestudy
AT stephaniesteigmeierraith efficacyofasingleinjectionofstromalvascularfractionindogswithelbowosteoarthritisaclinicalprospectivestudy
AT anjachristinawaselau efficacyofasingleinjectionofstromalvascularfractionindogswithelbowosteoarthritisaclinicalprospectivestudy
AT svenreese efficacyofasingleinjectionofstromalvascularfractionindogswithelbowosteoarthritisaclinicalprospectivestudy
AT andreameyerlindenberg efficacyofasingleinjectionofstromalvascularfractionindogswithelbowosteoarthritisaclinicalprospectivestudy